The leukemia charity, Anthony Nolan Trust, is to encourage people to spit so as to use saliva for matching bone marrows. The charity hopes that this measure will help double the number of lives saved.
The process is also pretty simple. People who want to register with the charity will be sent the saliva kits. They just have to fill a questionnaire, spit into the tube and send it back.
Advertisement
"Ultimately, this is about saving more lives. Anthony Nolan provides two potentially lifesaving transplants every day, but there is an equal number that we can't currently help," said Henny Braund, chief executive of Anthony Nolan. "We urgently need to increase the number of people on our register, and saliva testing will help us do that much more quickly and effectively."
The charity's research team has found that saliva tests are just as effective as blood typing. The charity has already run a pilot program that has seen 5,000 people join its register.
Source: Medindia
Source: Medindia
Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) is the cancer of white blood cells characterized by excess lymphoblasts. It is the most common of all childhood cancers and can be fatal in weeks if left untreated.
Advertisement
 Acute Myeloid LeukemiaAcute myeloid Leukemia, more popularly known by its abbreviated form AML, is a fast- evolving leukemia that affects both children and adults alike | Advertisement
|
Bone Marrow Transplantation - Animation
Animation and slides providing graphic explanation of Bone Marrow Transplantation (BMT)/Stem Cell Transplantation that is done for leukemia and other blood-related disorders.
Advertisement
Recommended Reading
Latest Organ Donation News
'Zombie' cell test could revive heart by reforming transplant criteria.
An analysis of data from donors suggests donor hearts from patients who were COVID-19 positive could place transplant patients at increased risk of mortality.
Patients subjected to delayed transplantation using 10°C static lung preservation had a better outcome compared to patients transplanted performed using standard methods.
Researchers are hoping to test the antibody IL-15 in organ transplant patients to reduce chronic organ rejection.
Research may speed the identification of patients who need liver transplants by analyzing blood samples to look for biomarkers associated with liver failure.